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Abstract Six new complexes of Zn(II), Cd(II) and Hg(II)
with sulphur containing ligand, tetraethylthiuram disul-
phide in 2:2 and 1:4 ratio have been synthesized. The
resulting complexes have been characterized on the basis
of molar conductance measurement, elemental analyses,
FT-IR, 1H-NMR, and FAB/ESI-mass studies. The com-
plexes were used as a single-source precursor for the
synthesis of ZnS/CdS/HgS nanoparticles by their thermal
decomposition in the presence of different surfactants. The
precursor:surfactant ratio and temperature play an impor-
tant role in determining the size of the nanoparticles. The
size and morphology of nanoparticles have been ascer-
tained by ultra violet–visible spectroscopy, X-ray diffrac-
tion measurements and transmission electron microscopy.
Schiff bases, complexes and nanoparticles were tested for
antibacterial activity and minimum inhibitory concentra-
tion values against Escherichia coli. The complexes were
found more potent than the corresponding Schiff bases and
nanoparticles.
Keywords Metal sulphide nanoparticles  Thermal
decomposition  Disulfiram  X-ray diffraction 
Transmission electron microscopy
Introduction
Recent progress in nanotechnology allows for the creation
of new materials with properties tunable on the nanometer
scale. Applications range from using fluorescent nanopar-
ticles as dyes for fluorescence labelling of cells and for
motility assays, using gold nanoparticles for immune
staining and gene delivery and using magnetic nanoparti-
cles as contrast agents for magnetic resonance imaging and
for hypothermia (Wu et al. 2003; Dahan et al. 2003; Lidke
et al. 2004). In addition to this, nanotechnology provides
products with specified and unique properties, which are
finding application in various branches of electronic,
chemical, food and textile industry as well as in medicine,
pharmacy, agriculture, architectural engineering, aviation
and in defense. It provides tools which allow to identifying
changes and taking repair operations on cellular and
molecular level and applying therapy oriented for specific
structures in cell.
Semiconductor nanoparticles show a characteristic
physicochemical property that differs from both the bulk
and the molecular substance. These properties open up their
use in diverse fields, such as optoelectronics, solar energy
conversion and photocatalysis. As a common semiconduc-
tor material, IIB transition metal chalcogenides have
attracted much attention due to their excellent properties and
wide range of potential applications (Hoffmann et al. 1995;
Brus 1991). These nanoparticles are important semicon-
ductor compounds and one of the most explored because of
their wide range of potential applications. ZnS has a wide
direct band gap of 3.65 eV (bulk) and it is a promising
material for optoelectronic device applications such as
optical coatings, solid-state solar cell windows, electrooptic
modulators, photoconductors, field-effect transistors, sen-
sors, transductors, light-emitting applications, and photonic
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crystal devices which operate in the region from visible to
near-infrared. CdS nanoparticles are the most studied sys-
tem amongst all the II–VI semiconducting nanoparticles.
Bulk CdS has a direct band gap of 2.42 eV at 300 K and a
typical Bohr exciton diameter of around 5.8 nm. As a result,
in the size range of 1–6 nm, CdS nanoparticles show sizable
quantum confinement effects. Cadmium sulphide shows
great potential for uses in photochemical catalysis, solar
cells, and nonlinear optical materials, and could be used as
bioorganic detector of proteins or DNA. Nanocrystalline
HgS has pronounced dichroism, photoelectric, acousto-
optic properties and electrostatic image properties. Thus, it
is a well-known technologically important material. Despite
these applications of HgS nanoparticles, relatively less study
is available due to difficulty in synthesis and toxicity of
mercury (Onwudiwe and Ajibadercury 2011).
In recent years, metal compounds with d10 electronic
configuration have received a lot of attention in the fields of
inorganic chemistry, biochemistry and environmental
chemistry. About 20 zinc enzymes are known in which zinc
is generally tetrahedrally four-coordinate and bonded to
hard donor atoms such as nitrogen (Marchettic et al. 1999).
Previously, it has been reported that Zn(II) and Cd(II)
complexes with Schiff base-type chelating ligand can be
used as an effective emitting layer and showed quite good
photo-physical properties (Kawamoto et al. 2008). Zinc
complexes have been shown to be active as antitumor, anti-
HIV and antimicrobial agents (Sheng et al. 2008; Ka-
czmareka et al. 2009; Cowley et al. 2005; Koike et al.
1996).
Disulfiram is a drug used to support the treatment of
chronic alcoholism by producing an acute sensitivity to
alcohol and treatment for cocaine dependence, as it pre-
vents the breakdown of dopamine (a neurotransmitter
whose release is stimulated by cocaine); the excess dopa-
mine results in increased anxiety, higher blood pressure,
restlessness and other unpleasant symptoms. Several stud-
ies have reported that it has anti-protozoal activity as well
(Nash and Rice 1998; Bouma et al. 1998). Disulfiram was
also chosen as a payload with micelle and liposome
nanoparticles on a mouse fibroblast cell L929. The toxic
effect observed was most likely not due to the disulfiram
delivered by the nanoparticles but rather to the amount of
free disulfiram that is present in the nanoparticle prepara-
tion (Lobler et al. 2009).
Therefore, in anticipation of an interesting chemistry
and biological activity, we have synthesized tetraethyl-
thiuram disulphide (TETD) complexes of Cd(II), Zn(II)
and Hg(II) in different molar ratio and characterized them
by spectroscopic methods. These complexes were further
used as a single-source precursor for the thermal synthesis
of metal sulphide nanoparticles. The actual aim of this
work is to validate how TETD metal derivative could be
used as single-source precursor for the thermal synthesis of
metal sulphide nanoparticles and to study and compare the
antibacterial activity of the Schiff bases, complexes and
nanoparticles synthesized.
Materials and methods
All the chemicals and solvents were used of A. R. grade.
Mercury (II) chloride, cadmium (II)chloride, tri-octyl-
phosphine oxide, triethanolamine, oleic acid, methanol,
toluene, TETD (disulfiram) (All E. Merck), hexadecyl-
amine (HDA) (Aldrich), zinc(II)chloride (CDH) were used
as received. Muffle furnace with digital temperature control
was used for thermal decomposition of complexes. Ele-
mental analysis (C, H, N, S) was performed on Elementra
Vario EL III Elemental Analyzer. Molar conductance
measurement of complexes was carried out in EI-181
Conductivity Bridge with dipping-type cell at 25 C. Shi-
madzu-1700, ultra violet–visible (UV–Vis) spectropho-
tometer was used to carry out the optical measurements and
the samples were placed in silica cuvettes (1 cm, path
length), using toluene as a reference solvent. Fourier
transform infrared spectra were recorded in KBr pellets on
Shimadzu-8400 PC, FT-IR spectrophotometer. 1H-nuclear
magnetic resonance spectra were recorded in MeOD on a
Bruker DRX-300 NMR spectrometer. Electrospray ioni-
zation mass spectra were recorded on Micromass Quattro II
mass spectrometer. X-ray diffraction (XRD) measurements
were carried out using Cu-Ka radiation (k = 0.154 nm)
with Bruker D8-Advance X-ray diffractometer and graphs
were plotted using Origin software. Transmission electron
microscopy photographs were taken on a Tecnai 20 G2 and
Image J software was used for the calculation of d-spacing.
Pcpdfwin software was used for matching calculated
d-spacing with standard values of d and hkl reflection
planes.
Synthesis of complexes
Synthesis of [Zn(TETD)Cl2]2, complex 1
Zinc chloride (0.273 g, 0.002 mol) was dissolved in 40 mL
of ethanol in a two-neck flask. The ligand TETD, (0.593 g,
0.002 mol), dissolved in 100 mL of ethanol, was added to
the above solution and stirred for 2–3 h. Thereafter, zinc
chloride (0.1366 g, 0.001 mol) dissolved in 20 mL ethanol,
was added to above reaction mixture. A light grey pre-
cipitate was obtained after refluxing 15–20 h in an inert
atmosphere, which was filtered, vacuum dried at room
temperature and recrystallized from ethanol:acetone:chlo-
roform, 1:1:2 (v/v) solvent mixture. Yield (0.796 g,
91.94 %), mp 120–125 C. found: C, 27.72; H, 4.66; N,
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6.41; S, 29.61 %. C20H40Cl4N4S8Zn2 requires: C, 27.75; H,
4.66; N, 6.47; S, 29.63 %; M, 859.84. Dm at 25 C
(X-1 cm2 mol-1): 13.2 in MeOH. Selected infrared
absorption (KBr, cm-1): m (CS), 812, 837w; m (C=S), 933,
987s; m (CN), 1,440, 1,472, 1,535s. 1H-NMR Spectra
(300 MHz, d, DMSO): d (CH3), 2.824–2.278 (t, 24 H);); d
(CH2), 1.378–1.181 (qrt, 16H).
13C-NMR Spectra
(300 MHz, d, DMSO): d (CH3), 13.84; d (CH2), 51.19; d
(C=S), 199.06. FAB-mass m/z: [ZnCl]? = 100.8;
[C4H10ClNZn]
? = 170.98; [C5H10ClNSZn]
? = 214.95;
[C5H10ClNS2Zn]
? = 246.92; [C5H10ClNS3Zn]
? = 278.9;
[C6H10ClNS4Zn]
? = 322.87; [C4H10Cl3NZn2]
? = 304.85;
[C6H10ClN2S4Zn]
? = 336.87; [C5H10Cl3NSZn2]
? = 348.82;
[C5H10Cl3NS2Zn2]
? = 380.79; [C10H20ClN2S4Zn]
? = 394.95;
[C5H10Cl3NS3Zn2]
? = 412.76; [C6H10Cl3NS4Zn2]
? = 456.73;
[C14H30ClN3S4Zn]
? = 467.03; [C15H30ClN3S5Zn]
? = 511.00;
[C10H20Cl3N2S4Zn2]
? = 528.82; [C15H30ClN3S6Zn]
? =
542.97; [C15H30ClN3S7Zn]
? = 574.95; [C16H30ClN3S8Zn]
? =
618.92; [C15H30Cl3N3S5Zn2]
? = 644.87; [C15H30Cl3N3S6Z
n2]
? = 674.84; [C20H40ClN4S8Zn]
? = 691.00; [C15H30Cl3N3
S7Zn2]
? = 708.81; [C16H30Cl3N3S8Zn2]
? = 752.79; [C20H40
Cl3N4S8Zn2]
? = 824.87; [C20H40Cl4N4S8Zn2 ? H
?]? =
860.84.
Synthesis of [Zn(TETD)4]Cl2, complex 2
Zinc chloride (0.136 g, 0.001 mol) was dissolved in 20 mL
of ethanol in a two-neck flask. The ligand TETD, (1.186 g,
0.004 mol), dissolved in 100 mL of ethanol, was added to
the above solution and stirred for 2–3 h. A dark-coloured
solution was obtained after refluxing 15–20 h, which was
evaporated and a dark grey-coloured precipitate was
obtained, which was dried at room temperature and re-
crystallized from ethanol:acetone:chloroform 1:2:3 (v/v)
solvent mixture. Yield, (1.088 g, 82.31 %), mp
140–145 C. found: C, 36.31; H, 6.01; N, 8.42; S,
38.73 %.C40H80N8S16ZnCl2 requires: C, 36.33; H, 6.09; N,
8.47; S, 38.79 %; M, 1,322.45. Dm at 25 C
(X-1 cm2 mol-1): 171.2 in DMSO. Selected infrared
absorption (KBr, cm-1): m (CS), 810, 862w; m (C=S), 937,
978s; m (CN), 1,448, 1,488s. 1H-NMR Spectra (300 MHz,
d, DMSO): d (CH3), 2.849–2.798 (m, 32H); d (C–H),
1.029–1.242 (m, 48H). 13C-NMR Spectra (300 MHz, d,




2? = 178.98; [C5H10NS2Zn]
2? = 211.95;
[C5H10NS3Zn]
2? = 243.93; [C6H10NS4Zn]
2? = 287.9;
[C6H10N2S4Zn]
2? = 301.9; [C10H20N2S4Zn]
2? = 359.98;
[C14H30N2S4Zn]
2? = 418.06; [C14H30N3S4Zn]
2? = 432.06;
[C15H30N3S5Zn]
2? = 476.03; [C15H30N3S6Zn]
2? = 508.01;
[C15H30N3S7Zn]
2? = 539.98; [C16H30N3S8Zn]
2? = 583.95;
[C16H30N4S8Zn]
2? = 597.95; [C20H40N4S8Zn]
2? = 656.03;
[C24H50N4S8Zn]
2? = 714.11; [C24H50N5S8Zn]
2? = 728.11;
[C25H50N5S9Zn]
2? = 772.08; [C25H50N5S10Zn]
2? = 804.06;
C25H50N5S11Zn]
2? = 836.03; [C26H50N5S12Zn]
2? = 880.00;
[C26H50N6S12Zn]
2? = 894.00; [C30H60N6S12Zn]
2? = 952.08;
[C34H70N6S12Zn]
2? = 1,010.16; [C34H70N7S12Zn]
2? =
1,024.16; [C35H70N7S13Zn]
2? = 1,068.14; [C35H70N7S14Z
n]2? = 1,100.11; [C35H70N7S15Zn]
2? = 1,132.08;
[C36H70N7S16Zn]




Synthesis of [Cd(TETD)Cl2]2, complex 3
Cadmium chloride (0.367 g, 0.002 mol) was dissolved in
30 mL of ethanol in a two-neck flask. The ligand TETD
(0.593 g, 0.002 mol), dissolved in 30 mL of ethanol, was
added to the above solution and stirred for 1–2 h in inert
atmosphere. Thereafter, cadmium chloride (0.173 g,
0.0009 mol mol) dissolved in 20 mL of ethanol, was added
to above reaction mixture. A light cream-coloured solution
obtained after a reflux of 18–20 h, was evaporated to yield a
dirty white precipitate, which was further recrystallized from
ethanol:acetone:chloroform, 1: 2: 2 (v/v) solvent mixture.
Yield, (0.933 g, 97.29 %), mp 185–190 C. found: C, 25.00;
H, 4.20; N, 5.82; S, 26.72 %. C20H40Cl4N4S8Cd2 requires:
C, 25.03; H, 4.20; N, 5.83; S, 26.73 %; M, 959.71. Dm at
25 C (X-1 cm2 mol-1): 20.6 in DMSO. Selected infrared
absorption (KBr, cm-1): m (CS), 805, 832w; m (C=S), 910,
977s; m (CN), 1,433, 1,479, 1,539s. 1H-NMR Spectra
(300 MHz, d, DMSO): d (CH3), 2.764–2.306 (t, 24 H);); d
(CH2), 1.162–1.431 (qrt, 16H).
13C-NMR Spectra (300 MH
z, d, DMSO): d (CH3), 15.38; d (CH2), 51.10; d (C=S),
200.22. FAB-mass m/z: [C5H10ClNCdS]
? = 264.93;
[C5H10ClNCdS2]
? = 296.9; [C5H10ClNS3Cd]
? = 328.87;
[C6H10ClNS4Cd]
? = 372.84; [C10H20ClN2S4Cd]
? = 444.92;
[C5H10Cl3NCd2S]
? = 448.77; [C5H10Cl3NCd2S2]
? = 4
80.74; [C14H30ClN2S4Cd]
? = 503.00; [C5H10Cl3NS3Cd2]
?
= 512.71; [C6H10Cl3NS4Cd2]
? = 556.68; [C15H30ClN3S5
Cd]? = 560.98; [C15H30ClN3S6Cd]
? = 592.95; [C15H30Cl
N3S7Cd]
? = 624.92; [C10H20Cl3N2S4Cd2]
? = 628.76; [C16
H30ClN3S8Cd]
? = 668.89; [C20H40ClN4S8Cd]
? = 740.97;
[C15H30Cl3N3S5Cd2]
? = 744.82; [C15H30Cl3N3S6Cd2]
? = 7
76.79; [C15H30Cl3N3S7Cd2]
? = 808.76; [C20H40Cl3N4S8Cd2]
?
= 924.82; [C20H40Cl4N4S8Cd2 ? H
?]? = 960.78.
Synthesis of [Cd(TETD)4]Cl2, complex 4
Cadmium chloride (0.183 g, 0.001 mol) was dissolved in
30 mL of ethanol in a two-neck flask. The ligand TETD
(1.186 g, 0.004 mol), dissolved in 50 mL of ethanol, was
added to the above solution and stirred for 2–3 h. A dark-
coloured solution was obtained after refluxing 15–20 h,
which was evaporated under vacuum to yield light grey-
coloured precipitate. The solid was recrystallized from
ethanol:acetone:chloroform, 1:2:4 (v/v) solvent mixture.
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Yield (1.210 g, 88.39 %), mp 205–210 C. found: C,
35.01; H, 5.72; N, 8.13; S, 37.42 %. C40H80Cl2N8S16Cd
requires: C, 35.08; H, 5.89; N, 8.18; S, 37.46 %; M,
1,369.47. Dm at 25 C (X-1 cm2 mol-1) 165.5 in MeOH.
Selected infrared absorption (KBr, cm-1): m (CS), 814,
856w; m (C=S), 917, 998s; m (CN), 1,421, 1,477s.
1H-NMR
Spectra (300 MHz, d, DMSO): d (CH3), 2.879–3.798 (m,
32H); d (CH2), 1.028–1.249(m, 48H).
13C-NMR Spectra
(300 MHz, d, DMSO): d (CH3), 14.21; d (CH2), 51.27; d
(C=S), 201.56. FAB-mass m/z: [C4H10NCd]
2? = 185.98;
[C5H10NSCd]
2? = 229.96; [C5H10NS2Cd]
2? = 261.93;
[C5H10NS3Cd]
2? = 293.9; [C6H10NS4Cd]
2? = 337.87;
[C6H10N2S4Cd]
2? = 351.88; [C10H20N2S4Cd]
2? = 409.95;
[C14H30N2S4Cd]
2? = 468.03; [C14H30N3S4Cd]
2? = 482.04;
[C15H30N3S5Cd]
2? = 526.01; [C15H30N3S6Cd]
2? = 557.98;
[C15H30N3S7Cd]
2? = 589.95; [C16H30N3S8Cd]
2? = 633.92;
[C16H30N4S8Cd]
2? = 647.93; [C20H40N4S8Cd]
2? = 706.01;
[C24H50N4S8Cd]






2? = 886.00; [C26H50N5S12Cd]
2? = 929.97;
[C26H50N6S12Cd]
2? = 943.98; [C30H60N6S12Cd]
2? =
1,002.06; [C34H70N6S12Cd]
2? = 1,060.13; [C34H70N7S12C
d]2? = 1,074.14; [C35H70N7S13Cd]
2? = 1,118.11; [C35H70
N7S14Cd]
2? = 1,150.08; [C35H70N7S15Cd]
2? = 1,182.05;
[C36H70N7S16Cd]




Synthesis of [Hg(TETD)Cl2]2, complex 5
Mercury chloride (0.543 g, 0.002 mol) was dissolved in
30 mL of ethanol in a two-neck flask. The ligand TETD
(0.593 g, 0.002 mol) dissolved in 30 mL of ethanol was
added to the above solution and stirred for 2–3 h. There-
after, mercury chloride (0.136 g, 0.0005 mol) dissolved in
20 mL ethanol, was added to above reaction mixture. A
colourless solution was obtained after refluxing 18–20 h,
which was evaporated under vacuum to yield light grey
precipitate, which was dried at room temperature and re-
crystallized from ethanol:acetone:chloroform, 1:1:1 (v/v)
solvent mixture. Yield (0.956 g, 84.14 %), mp
135–140 C. found: C, 21.11; H, 3.55; N, 4.92; S, 22.56 %.
C20H40Cl4N4S8Hg2 requires: C, 21.14; H, 3.55; N, 4.93; S,
22.58 %; M, 1,136.07. Dm at 25 C (X-1 cm2 mol-1): 17.9
in DMSO. Selected infrared absorption (KBr, cm-1): m
(CS), 808, 839w; m (C=S), 912, 983s; m (CN), 1,454, 1,492,
1,550s. 1H-NMR Spectra (300 MHz, d, DMSO): d (CH3),
2.949–2.720 (t, 24 H);); d (CH2), 1.492–1.196 (qrt, 16H).
13C-NMR Spectra (300 MHz, d, DMSO): d (CH3), 11.77; d
(CH2), 51.06; d (C=S), 201.27. ESI-mass m/z:
HgCl]? = 236.7; [Hg202Cl]? = 238.7; [C4H10ClNHg]
? =
309.02; [C5H10ClNHg
202S]? = 355.0; [C5H10ClNHgS2]
?=
384.96; [C6H10ClNS4Hg]
? = 460.91; [C6H10ClNS3.S
34Hg]?
= 462.91 [C10H20ClN2S4Hg]
? = 532.99; [C14H30ClN2S4H
g]? = 591.07; [C14H30ClN3S4Hg]
? = 604.90; [C14H30ClN2.
N15S4Hg]
? = 605.90 [C5H10Cl3NHg2S2]
? = 656.87; [C12
H20ClN2S8Hg]




202]? = 758.0; [C20H40ClN4S8Hg]
? = 82
9.04; [C20H40Cl2N4S8Hg]
? = 864.01; [C20H40Cl2N3.N
15S8
Hg] = 865.01. [C15H30Cl3N3Hg2S6]
? = 952.92; [C20H40Cl3
N4S8Hg2]
? = 1,100.95; [C20H40Cl4N4S8Hg2]
? = 1,135.92.
C20H40Cl4N4S8Hg2 (Ms = 1,136.07), requires: C, 21.14; H,
3.55; N, 4.93; S, 22.58. Found: C, 21.11; H, 3.55; N, 4.92; S,
22.56.
Synthesis of [Hg(TETD)4]Cl2, complex 6
Mercury chloride (0.272 g, 0.001 mol) was dissolved in
50 mL of ethanol in a two-neck flask. The ligand TETD
(1.186 g, 0.004 mol), dissolved in 100 mL of ethanol, was
added to the above solution and stirred for 2–3 h. A col-
ourless solution was obtained after refluxing 18–20 h,
which was evaporated and greyish precipitate was obtained,
which was dried at room temperature and recrystallized
from ethanol:acetone:chloroform, 1:2:2 (v/v) solvent mix-
ture. Yield (1.345 g, 92.25 %), mp 85–90 C. Found: C,
32.91; H, 5.50; N, 7.62; S, 35.13 %. C40H80Cl2N8S16Hg
requires: C, 32.95; H, 5.53; N, 7.69; S, 35.20 %; M,
1,457.65. Dm at 25 C (X-1 cm2 mol-1): 159.6 in DMSO.
Selected infrared absorption (KBr, cm-1): m (CS), 817,
847w; m (C=S), 908, 972s; m (CN), 1,446, 1,483s.
1H-NMR
Spectra (300 MHz, d, DMSO): d (CH3), 2.938–2.833 (t,
32H); d (CH2), 1.251–1.036(qrt, 32H).
13C-NMR Spectra
(300 MHz, d, DMSO): d (CH3), 10.82; d (CH2), 51.48; d
(C=S), 203.97. FAB-mass m/z: [C4H10NHg]
2? = 274.05;
[C5H10NSHg]
2? = 318.02; [C5H10NS2Hg]
2? = 350.00;
[C5H10NS3Hg]
2? = 381.97; [C6H10NS4Hg]
2? = 425.94;
[C6H10N2S4Hg]
2? = 439.94; [C10H20N2S4Hg]
2? = 498.02;
[C14H30N2S4Hg]
2? = 556.10; [C14H30N3S4Hg]
2? = 570.10;
[C15H30N3S5Hg]
2? = 614.07; [C15H30N3S6Hg]
2? = 646.05;
[C15H30N3S7Hg]
2? = 678.02; [C16H30N3S8Hg]
2? = 721.99;
[C16H30N4S8Hg]
2? = 735.99; [C20H40N4S8Hg]
2? = 794.07;
[C24H50N4S8Hg]
2? = 852.15; [C24H50N5S8Hg]
2? = 866.15;
[C25H50N5S9Hg]
2? = 910.13; [C25H50N5S10Hg]
2? = 942.
10; [C25H50N5S11Hg]
2? = 974.07; [C26H50N5S12Hg]
2? =
1,018.04; [C26H50N6S12Hg]
2? = 1,032.05; [C30H60
N6S12Hg]
2? = 1,090.12; [C34H70N6S12Hg]
2? = 1,148.20;
[C34H70N7S12Hg]
2? = 1,162.20; [C35H70N7S13Hg]
2? =
1,206.18; [C35H70N7S14Hg]
2? = 1,238.15; [C35H70N7S15
Hg]2? = 1,270.12; [C36H70N7S16Hg]
2? = 1,314.09; [C36H70
N8S16Hg]
2? = 1,328.10; [C40H80N8S16Hg]
2? = 1,386.17.
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Synthesis of nanoparticles by thermal decomposition
ZnS nanoparticles
The synthesized complex [Zn(TETD)Cl2]2/[Zn(TETD)4]
Cl2, (0.1 mmol) was mixed with triethanolamine
(0.027 mL, 0.2 mmol) and oleic acid (0.063 mL,
0.2 mmol) in 12 mL of toluene in a flat-bottom microfl-
ask equipped with a glass lid. Reaction mixture was
mixed thoroughly and the closed microflask was kept in a
muffle furnace at *200 C for 1 h. Thereafter, furnace
was cooled till normal temperature was attained. A
change in colour of reaction mixture was observed and a
light brown precipitate was obtained. The insoluble pre-
cipitate was washed several times by toluene, followed by
methanol and then centrifuged. It was vacuum dried at
room temperature. The experiment was performed at
different precursor:surfactant ratio at different temperature
(Table 1).
CdS nanoparticles
The synthesized complex [Cd(TETD)Cl2]2/[Cd(TETD)4]
Cl2, (0.2 mmol) was mixed with hexadecylamine (0.289 g,
1.2 mmol) in 10 mL of toluene in a flat-bottom microflask.
Reaction mixture was mixed thoroughly and the closed
microflask was kept in a muffle furnace at *300 C for
1 h. Thereafter, furnace was cooled till normal temperature
was attained. A change in colour was observed and a yel-
low precipitate was obtained. Insoluble precipitate was
washed several times by toluene, followed by methanol and
then centrifuged. It was vacuum dried at room temperature.
The experiment was performed at different precursor:sur-
factant ratio at different temperature (Table 1).
HgS nanoparticles
The synthesized complex, [Hg(TETD)Cl2]2/[Hg(TETD)4]
Cl2, (0.05 mmol) was mixed with tri-octylphosphine oxide
(0.39 g, 0.1 mmol) in 10 mL of toluene in a flat-bottom
microflask. Reaction mixture was mixed thoroughly and
heated in a muffle furnace at *200 C for 1 h and cooled.
After cooling, colour of the reaction mixture was changed
and a black precipitate was obtained. Insoluble precipitate
was washed by toluene followed by methanol and centri-
fuged, and then it was vacuum dried at room temperature.
The experiment was performed at different precursor:sur-
factant ratio at different temperature (Table 1).
Antibacterial screening
All the metal complexes from 1 to 6, ligand TETD and the
nanoparticles of CdS, ZnS and HgS were screened for
antibacterial activity against Gram-negative bacteria
Escherichia coli, MTCC 1304 at different concentrations.
Mueller-Hinton agar plates (MHA) were prepared and
50 lL suspensions of E. coli containing *105 CFU (col-
ony-forming unit) were applied to the plate by the well-
diffusion method. The wells were made on the plates and
they were filled with 50 lL of sample solution of 0.02 %
concentration except in nanoparticles, where 0.02 % dried
samples were introduced as such in the well. The 0.02 %
solution of chloramphenicol was used for comparison.
These plates were incubated at 37 ± 1 C for 24–48 h in
Table 1 Effect of
precursor:surfactant ratio on the
size of nanoparticles
Complexes Surfactant Ratio of
complex:surfactant
Mean particle size of
nanoparticles from
complexes (nm)
1, 2 Triethanolamine 1:1 15.5; 15.90
1, 2 Triethanolamine 1:2 8.95; 8.99
1, 2 Triethanolamine 1:3 8.90; 8.94
1, 2 Triethanolamine 1:4 8.94; 8.63
1, 2 Triethanolamine 1:5 8.98; 8.79
3, 4 Hexadecylamine 1:1 30.45; 30.87
3, 4 Hexadecylamine 1:2 26.57; 26.46
3, 4 Hexadecylamine 1:3 26.26; 26.12
3, 4 Hexadecylamine 1:4 26.56; 26.37
3, 4 Hexadecylamine 1:5 26.60; 26.72
5, 6 Tri-octylphosphine oxide 1:1 13.45; 13.89
5, 6 Tri-octylphosphine oxide 1:2 9.85; 9.2
5, 6 Tri-octylphosphine oxide 1:3 9.56; 9.82
5, 6 Tri-octylphosphine oxide 1:4 9.89; 9.70
5, 6 Tri-octylphosphine oxide 1:5 9.90; 9.32
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refrigerated incubator shakers. The results in the form of
zone inhibition, measured in millimetres, are presented in
Table 2.
Minimum inhibitory concentration (MIC)
To monitor the activity and confirm their sensitivity com-
plexes from 1 to 6 and nanoparticles were tested for MIC.
The most popular method for MIC evaluation, commonly
used in clinical laboratory, is successive dilution method.
In six numbered screw tubes A–F (10 9 100 mm),
1 mL of Mueller-Hinton broth medium was distributed in
each tube, except for the tube A. All the tubes were placed
at autoclave for sterilization. In tubes A and B, 1 mL of test
solution (1–6) was added; tube B was stirred and 1 mL of
mixture of the same was taken out and transferred to tube
C. The 0.1 mL suspension of inoculums E. coli, MTCC
1304 having *500,000 cells per lL was added to all tubes.
Incubation at 37 ± 1 C temperature was maintained for
24–48 h. MIC is concentration of the higher dilution tube,
in which bacterial growth was absent and the results are
presented in Table 2.
Results and discussion
Six complexes of Zn(II), Cd(II) and Hg(II) were prepared
according to the following equations:
where M = Zn(II), Cd(II) and Hg(II).
Characterization of the complexes
Empirical formula of all the complexes 1–6 was in confor-
mity with the elemental analysis. Molecular weights of all the
complexes were confirmed by FAB-MS. A number of peaks
were observed in mass spectra. Some important peaks, which





?]?. However, 1:4 complexes of
TETD show [C40H80N8S16M]
2?. The complex 5 was also
studied by ESI–MS (Fig. 1 in supplementary file). ESI- MS
spectra of complex 5 exhibit the signals at 236.7, 238.7,
309.02, 355.0, 384.96, 460.91, 462.91, 532.99, 591.07,
604.90, 605.90, 656.87, 684.0, 685.0 758.0, 829.04, 952.92,





























Molar conductance values for all 2:2 complexes of
dilute concentration (*5.0 mmol) were in the range
10.0–20.6 X-1 cm2 mol-1 suggesting non-electrolytic
nature of the complexes. However, in 1:4 complexes, molar
conductance values were quite higher and in the range
160–180 X-1 cm2 mol-1, indicating 1:2 electrolytic nat-
ures of the complexes.
According to FT-IR spectra of ligand (Fig. 2 in sup-
plementary file), sharp two absorption bands exhibited at
991 and 1,046 cm-1, assigned for m (C=S) were found
shifted to lower frequency region and observed at about
912 and 983 cm-1 in the complexes, indicating coordina-
tion of metal to sulphur of the thiocarbonyl moiety (Nabeel













TETD ? 18 0.68
1. [ZnCl2(TETD)]2 ? 20 0.39
2. [Zn(TETD)4]Cl2 ? 23 0.34
3. [CdCl2(TETD)]2 ? 42 0.35
4. [Cd(TETD)4]Cl2 ? 34 0.31
5. [HgCl2(TETD)]2 ? 34 0.25
6. [Hg(TETD)4]Cl2 ? 38 0.23
i. ZnS nanoparticle ? 17 0.28
ii. CdS nanoparticle ? 28 0.26
iii. HgS nanoparticle ? 26 0.20
C. Chloramphenicol ? 42 –
a Diameter of inhibition zone[8 mm is taken as active and is shown
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et al. 2005). The complexes 1, 3 and 5 display bands
characteristic of coordinated tetraethylthiuram disulphide
(disulphiram), strong absorption in between 1,433–1,545
and 912–987 cm-1 due to m (C–N) and m (C=S) modes,
which indicate the presence of bidentate bridging nature of
disulfiram ligand in these complexes. A shift to higher
frequency in the m (C–N) bands of the binuclear complexes
as compared to the ligand indicates the increase in double
bond character of the C–N bond.
In 1H-NMR spectra of the complexes (Fig. 3 in sup-
plementary file), triplet ascribed for the –CH3 proton and
quartet assigned for –CH2 proton in ligand were almost
unshifted and observed at same d value.
In 13C-NMR spectra of complexes (Fig. 4 in supple-
mentary file), a signal observed at about d 192.56 ppm
for thiocarbonyl carbon in ligand was shifted to lower
field and appeared at about *d 200 ppm in the com-
plexes indicating coordination of ligand to metal by
donating lone pair from sulphur of the thiocarbonyl
moiety. In all the complexes, signal assigned for methyl
carbon (–CH3) and methylene carbon (CH2) was observed
at the same position as it was observed in their corre-
sponding ligand.
Therefore, on the basis of molar conductance, elemental
analyses, FT-IR, 1H-NMR, 13C-NMR FAB-mass and ESI-
mass, the most probable structure for the complexes was
suggested as in Figs. 1 and 2.
Characterization of nanoparticles
UV–visible spectra of CdS nanoparticles
UV–Vis absorption spectroscopy is an efficient technique
to monitor the optical properties of quantum-sized par-
ticles. It can be used as a convenient method of char-
acterizing the size and size distribution of semiconductor
nanoparticles. Semiconductor nanocrystallite are known
to have an absorption edge, which is shifted with respect
to the bulk material towards shorter wavelengths. This
blue shift is thus taken as an indication of the presence
of such nanocrystals. The UV–Vis spectra of CdS
nanoparticles were recorded in transmission mode and
samples were prepared by making dispersion in toluene.
For the bulk crystallites, we usually observe the inter-
band absorption spectrum with a band edge around
515 nm. As the crystalline size decreases there is a blue
shift of the absorption edge. In the present case, the band
edge is observed at 406 nm with a further shoulder at
about 380 nm realizing that our CdS nanoparticles’
sample may not be strictly monodispersed. A similar
feature for the UV–Vis spectrum of the nanocrystalline
CdS has been reported by Motte (1992) and Hoyer et al.
(1995).
X-ray diffraction (XRD) measurements
XRD pattern provides information about crystalline phase
of the nanoparticles as well as the crystallite size (Nair
et al. 2002). Mean crystallite size was also calculated using
Scherrer’s formula (Manickathai et al. 2008). In XRD
pattern of ZnS (Fig. 3), prominent peaks were obtained at
26.5417, 32.978 and 28.2578. The calculated corre-
sponding d-spacings are 3.36, 2.71 and 3.16 indicating the
presence of (100), (101) and (002) reflection plane and
hexagonal phase of nanoparticles. The estimated average
crystalline grain size of ZnS sample is 3.6 nm.
The XRD of CdS nanoparticles (Fig. 4) exhibits prom-
inent peaks at 28.2297, 24.8538 and 26.5417 corre-
sponding to calculated d-spacings 3.16, 3.58 and 3.35,
Fig. 1 Structure of complexes 1, 3 and 5, where M: Zn, Cd and Hg
Fig. 2 Structure of complexes 2, 4 and 6, where M: Zn, Cd and Hg
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respectively, indicating the presence of (101), (100) and
(002) reflection planes in accordance with hexagonal
phase. The XRD of CdS also exhibits peaks at 43.7586,
48.9222 and 51.8888 corresponding to d-spacings 2.06,
1.89 and 1.76 indicating the presence of (110), (103) and
(112) reflection planes also supports the existence of hex-
agonal phase (Yadav et al. 2009; Kandasamy et al. 2009).
The estimated average grain size of sample is 16.12 nm
obtained from the FWHM of most intense peak.
In XRD pattern of HgS nanoparticles (Fig. 5), promi-
nent peaks were obtained at 26.4433, 28.1663 and
43.8219 corresponding to d-spacings 3.37, 3.17 and 2.06
indicating the presence of (101), (012) and (104) reflection
planes. The estimated mean grain size of the sample is
5.78 nm.
Transmission electron microscopy
TEM allows the direct imaging of nanoparticles and pro-
vides more information on the quality of individual parti-
cles, e.g. their size, distribution and shape (Hambrock et al.
2001). The TEM image of ZnS nanoparticles (Fig. 6a)
shows quite well-defined particles with narrow size distri-
bution between 5.6 and 16.9 nm with a mean particle size
of 8.9 nm (see Table 1). The selective area electron dif-
fraction pattern (SAED) for ZnS exhibits broad diffused
rings that are typical of nano-sized particles and a repre-
sentative pattern is shown in Fig. 6b. The d-spacing values
calculated from the SAED pattern are 3.552, 3.205 and
2.853, which are in a good agreement with the XRD
results. The size distribution graph is shown in (Fig. 6c).
The TEM image of CdS nanoparticles (Fig. 7a) shows
quite well-defined hexagonal particles with a narrow size
distribution from 13.3 to 37.5 nm and mean particle size
26.46 nm (see Table 1). The SAED for CdS exhibits broad
diffused rings that are typical of nano-sized particles
(Fig. 7b). The d-spacing values calculated from the SAED
pattern are 3.46, 2.09 and 1.80, which are in a good
agreement with the XRD results. The size distribution
graph is shown in Fig. 7c.
The TEM image of HgS nanoparticles (Fig. 8a) shows
quite well-defined hexagonal particles with a narrow size
distribution from 5.8 to 15 nm and mean particle size
9.2 nm (see Table 1). The SAED for HgS exhibits broad
diffused rings that are typical of nano-sized particles and a
representative pattern is shown in Fig. 8b. The d-spacing
values calculated from the SAED pattern are 3.508, 2.114
and 1.780, which are in a good agreement with the XRD
results. The size distribution graph is shown in Fig. 8c.
Antibacterial activity
All the metal complexes from 1 to 6, ligand TETD and the
nanoparticles of CdS, ZnS and HgS were screened for
Fig. 3 XRD pattern of ZnS nanoparticles
Fig. 4 XRD pattern of CdS nanoparticles
Fig. 5 XRD pattern of HgS nanoparticles
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antibacterial activity against Gram-negative bacteria
E. coli, MTCC 1304 at different concentrations. MHA
were prepared and 50 lL suspensions of E. coli containing
*105 CFU (colony-forming unit) were applied to the plate
by the well-diffusion method (Pelczar et al. 2001). The
wells were made on the plates and they were filled with
50 lL of sample solution of 0.02 % concentration except
in nanoparticles, where 0.02 % dried samples were intro-
duced as such in the well. The 0.02 % solution of
chloramphenicol was used for comparison. These plates
were incubated at 37 ± 1 C for 24–48 h in refrigerated
incubator shakers. The results in the form of zone inhibi-
tion were measured in millimetres. It was observed that all
metal complexes show more activity in comparison to
ligand, probably due to enhanced lipophilicity of the
complexes, which leads to the breakdown of permeability
barrier of the cell and thus retards the normal cell process
in bacteria. It is postulated that improved activity arises
Fig. 6 a TEM image of ZnS
nanoparticles. b SAED pattern
of ZnS nanoparticles.
c Distribution graph of different
size of ZnS nanoparticles
Fig. 7 a TEM image of CdS
nanoparticles. b SAED pattern
of CdS nanoparticles.
c Distribution graph of different
size of CdS nanoparticles
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from the delocalization of positive charge between the
organic moiety and the metal, which favours the drug
entering into normal cellular processes of the bacteria.
The increased activity of metal complexes can be
explained on the basis of ‘Overtone’s concept’ and ‘Che-
lation theory’. According to ‘Overtone’s concept’ of cell
permeability, the lipid membrane that surrounds the cell
favours the passage of only lipid-soluble materials due to
which liposolubility is an important factor that controls the
antimicrobial activity. On Chelation, the polarity of metal
ion will reduce to a greater extent due to overlap of the
ligand and metal orbital and partial sharing of positive
charge of the metal ion with donor groups.Further, it
increases the delocalization of p-electrons over the whole
chelate ring, which enhance the lipophilicity of the com-
plexes into lipid membrane and blocks the metal binding
sites on enzyme of pathogenic microorganism. However, it
was interestingly observed that nanoparticles exhibited
more activity than Schiff base but less than corresponding
complexes (see Figs. 5 and 6 of supplementary file). The
detail result of antibacterial screening for 0.02 % concen-
tration is given in Table 2.
Minimum inhibitory concentration (MIC)
To monitor the activity and confirm their sensitivity,
complexes from 1 to 6 and nanoparticles were tested for
MIC by successive dilution method (Mazzola et al. 2009).
In six numbered screw tubes A–F (10 9 100 mm),
1 mL of Mueller-Hinton broth medium was distributed in
each tube, except for the tube A. All the tubes were placed
at autoclave for sterilization. In tubes A and B, 1 mL of test
solution (1–6) was added; tube B was stirred and 1 mL
mixture of the same was taken out and transferred to tube
C. The 0.1 mL suspension of inoculums E. coli, MTCC
1304 having *500,000 cells per lL was added to all tubes.
Incubation at 37 ± 1 C temperature was maintained for
24–48 h. MIC is concentration of the higher dilution tube,
in which bacterial growth was absent and the results are
presented in Table 2. It was observed that complex 3 was
the most active to inhibit bacteria with inhibition zone of
42 mm and minimum inhibitory concentration of 0.35 lg/
mL for E. coli. Mercury complexes 5 and 6 and their
nanoparticles have lower MIC value in between 0.20 and
0.25 lg/mL. However, it was interestingly observed that
MIC of metal sulphide nanoparticles is lower than in cor-
responding metal complexes, which may be attributed to
the increased ratio of surface area to volume in the
nanoparticles.
Conclusions
Six complexes of Zn(II), Cd(II) and Hg(II) with ligand
TETD have been synthesized and characterized by spec-
troscopic methods. These complexes along with surfactant
in the ratio ranging between 1:1 and 1:5 for precur-
sor:surfactant were used as single-source precursor for the
thermal/pyrolytic synthesis of ZnS, CdS and HgS nano-
particles. Interestingly, it was observed that, at low con-
centration of precursor and high concentration of surfactant
the nanoparticles are hexagonal in shape and smaller in
Fig. 8 a TEM image of HgS
nanoparticles. b SAED pattern
of HgS nanoparticles.
c Distribution graph of different
size of HgS nanoparticles
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size. In synthesis of nanoparticles 1:2, precursor:surfactant
ratio is most favourable. At high temperature, agglomera-
tion takes place and large particle size is favoured. In this
work, Schiff base complexes were probably for the first
time used as single-source precursor for the synthesis of
metal sulphide nanoparticles. All the complexes were
screened for antibacterial activity against E. coli and found
more potent than Schiff base ligands and exhibit approxi-
mately same toxicity as standard drug. However, nano-
particles exhibited more antibacterial activity than Schiff
bases but less than corresponding complexes. It can be
concluded that nanoparticles exhibited potency due to their
greater surface area, but the synergistic effect of toxophoric
functions is more prominent in the complexes, due to
which probably complexes are more potent than nanopar-
ticles. Interestingly, nanoparticles exhibit lower MIC than
complexes probably due to their higher surface activity.
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